Clinical Trial Update: Degludec Glargine U300 Hospital Study [NA]

View source ↗

Summary

A completed hospital-based clinical trial in India compared insulin degludec (Tresiba) with insulin glargine U300 (Toujeo) for type 2 diabetes. The study was sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TOUJEO (insulin glargine)
• Tresiba (insulin degludec)

Snippet

Sponsor: Medanta, The Medicity, India | Conditions: Type 2 Diabetes | NA | Status: COMPLETED